On January 28th, President Trump ordered a travel ban for all citizens from seven Muslim-majority countries for 90 days and for all refugees for 180 days. Spontaneous protests erupted at airports and borders all over the country, particularly over detainees who held visas or green cards. The American Civil Liberties Union (ACLU) filed a suit...
The “Specific Aims” is one of the most important and challenging portions of a National Institutes of Health grant application. Fortunately, a new session at ENDO 2017 will provide personal feedback and will grant writers with senior reviewers for one-on-one input. A new offering at ENDO 2017 promises to be a highlight for many in-training...
On January 12, the Centers for Medicare and Medicaid Services (CMS) announced that it would be including continuous glucose monitors (CGM) in a new category of durable medical equipment for therapeutic use. This ruling follows many years of advocacy by the Endocrine Society (ES) and its coalition partners to expand coverage for CGM to the...
On Thursday, December 1, Janine Austin Clayton, MD, director of the NIH Office of Research on Women’s Health (ORWH) and associate director of Women’s Health Research at the NIH visited the Endocrine Society for a meeting with Endocrine Society member and associate director of the Center for Women’s Health Research at the University of Colorado...
Senate Majority Leader Mitch McConnell (R-KY) has announced that a resolution to allow for the replacement of the healthcare law would be the first item of business for the Senate in the next Congress, starting Jan. 3. It is expected that to dismantle the law, Congress will use a budget process, known as reconciliation, that...
For the second year in a row, Endocrine News talks to editors from Endocrine Society journals to get the scoop on the top endocrine discoveries of 2016. The life work of a scientist requires an enormous amount of patience. “Eureka moments” take years of tireless experimentation and iteration to achieve, which is why impactful discoveries...
The Endocrine Society lauds Novo Nordisk’s recent announcement that it would limit price increases for its therapies, including insulin, and hopes that other entities in the insulin supply chain including manufacturers, pharmacy benefit managers, and insurers will also demonstrate similar restraint to address this important issue. People with type 1 diabetes are unable to produce...
With the presidential election on the horizon and NIH funding hanging in the balance, the Endocrine Society’s members have been especially active on Capitol Hill this fall. In September, the Society held a widely attended briefing on Capitol Hill about the public health impacts of endocrine-disrupting chemicals (EDCs), attended a hearing on an important piece...
Not all topics of relevance to endocrinologists are about specific conditions and diseases. Sometimes, doctors need information about changes in the medical field or the field of endocrinology. Changes to medical insurance legislation, drug trial regulations and even patient privacy legislation all impact a practitioner’s way of doing business and practicing medicine. Yet keeping track of these details is not always easy. That’s why Endocrine News has organized articles and news pieces on these topics into this advocacy page. Here, practitioners can find the information gathered by the Endocrine Society, a leading endocrinology advocacy organization, conveniently in one location.
Important Advocacy Information From the Endocrine Society
As an endocrinology advocacy organization, the Endocrine Society is constantly working to advocate for endocrinologists and their patients, both in the government and in various research centers across the country. Here on Endocrine News, you can stay informed about these efforts and their results, so you are well aware of what changes may be coming that affect your practice. This is an invaluable resource for doctors who wish to spend their time focusing on their patients, rather than advocating for their practices, but also wish to stay informed about what is happening in the field.
Both Clinical and Research Advocacy Information
On the Advocacy page, Endocrine News provides advocacy information relevant to both those in the research field and those practicing on a clinical level. Stay up to date with the activities of the Endocrine Society, learn more about the legislation that affects your work, and see highlights of leading researchers who are pioneering not only advances in the practice but also advocacy for endocrinology as a field. By utilizing the resources on the Advocacy page, you will be better equipped to meet the needs of your patients while staying abreast on the changes affecting the industry.
On January 28th, President Trump ordered a travel ban for all citizens from seven Muslim-majority countries for 90 days and for all refugees for 180 days. Spontaneous protests erupted at airports and borders all over the country, particularly over detainees who held visas or green cards. The American Civil Liberties Union (ACLU) filed a suit...
For the second year in a row, Endocrine News talks to editors from Endocrine Society journals to get the scoop on the top endocrine discoveries of 2016. The life work of a scientist requires an enormous amount of patience. “Eureka moments” take years of tireless experimentation and iteration to achieve, which is why impactful discoveries...
